教育背景（从本科填）

2008年-2013年蚌埠医学院医学检验专业本科

2013年-2019年复旦大学病原生物专业硕士/博士

学位论文及研究生期间发表论文

学位论文题目《广谱抗人冠状病毒多肽类融合抑制剂的研究》

发表论文：……

1. S. Xia, W. Xu, Q. Wang, C. Wang, C. Hua, W. Li, L. Lu, S. Jiang, Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains Int J Mol Sci. 19, (2018).

2. C. Wang, S. Xia, P. Zhang, T. Zhang, W. Wang, Y. Tian, G. Meng, S. Jiang, K. Liu, Discovery of Hydrocarbon-Stapled Short alpha-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. J Med Chem. 61, 2018-2026 (2018).

3. Li, F. Yu, S. Xia, Y. Yu, Q. Wang, M. Lv, Y. Wang, S. Jiang, L. Lu, Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles Antimicrob Agents Chemother. 61, (2017).

4. Su, Y. Zhu, S. Ye, Q. Qi, S. Xia, Z. Ma, F. Yu, Q. Wang, R. Zhang, S. Jiang, L. Lu, Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors. J Virol. 91, (2017).

5. F. Yu, H. Song, Y. Wu, SY Chang, L. Wang, W. Li, B. Hong, S. Xia, C. Wang, S. Khurana, Y. Feng, Y. Wang, Z . Sun, B. He, D. Hou, J. Manischewitz, LR King, Y. Song, JY Min, H. Golding, X. Ji, L. Lu, S. Jiang, DS Dimitrov, T. Ying, A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin. Cell Host Microbe. 22, 471-483.e475 (2017).

6. B. He, Y. Fu, S. Xia, F. Yu, Q. Wang, L. Lu, S. Jiang, Intranasal application of polyethyleneimine suppresses influenza virus infection in mice. Emerg Microbes Infect. 5, e41 (2016 )

7. S. Xia, Q. Wang, S. W. Liu, L. Lu, S. B. Jiang, [Development of peptidic MERS-CoV entry inhibitors]. Yao Xue Xue Bao. 50, 1513-1519 (2015).

8. Z. Sun, Q. Wang, R. Jia, S. Xia, Y. Li, Q. Liu, W. Xu, J. Xu, L. Du, L. Lu, S. Jiang, Intranasal administration of maleic Anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection. Viruses. 7, 798-819 (2015).

9. R. Channappanavar, L. Lu, S. Xia, L. Du, DK Meyerholz, S. Perlman, S. Jiang, Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection. J Infect Dis. 212, 1894-1903 (2015).

10. Q. Liu, S. Xia, Z. Sun, Q. Wang, L. Du, L. Lu, S. Jiang, Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry. Antimicrob Agents Chemother 59, 742-744 (2015).

11. L. Lu, S. Xia, T. Ying, S. Jiang, Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS). Emerg Microbes Infect. 4, e37 (2015) .

12. S. Xia, Q. Liu, Q. Wang, Z. Sun, S. Su, L. Du, T. Ying, L. Lu, S. Jiang, Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors Target spike protein. Virus Res. 194, 200-210 (2014).

获奖情况

2011年度蚌埠医学院优秀学生奖学金

2012年度蚌埠医学院优秀学生奖学金

2013年度复旦大学三等学业奖学金

2014年度复旦大学优秀硕士学业奖学金

2015年度复旦大学优秀硕士学业奖学金

2016年度复旦大学冠名奖学金

毕业去向

留在原实验室做博后